Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000546296 | SCV000649289 | likely benign | Neuropathy, hereditary sensory and autonomic, type 2A; Generalized epilepsy with febrile seizures plus, type 7 | 2024-10-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002413369 | SCV002719326 | uncertain significance | Inborn genetic diseases | 2020-05-14 | criteria provided, single submitter | clinical testing | The p.T649M variant (also known as c.1946C>T), located in coding exon 12 of the SCN9A gene, results from a C to T substitution at nucleotide position 1946. The threonine at codon 649 is replaced by methionine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Bioinformatics Core, |
RCV000655987 | SCV000588263 | pathogenic | Self-limited epilepsy with centrotemporal spikes | 2017-01-01 | no assertion criteria provided | case-control | CAADphred>15 |